State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.
Key Laboratory of Biosynthesis of Natural Products of National Health Commission, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.
Molecules. 2018 Oct 28;23(11):2797. doi: 10.3390/molecules23112797.
Glycosylation, which is catalyzed by UDP-glycosyltransferases (UGTs), is an important biological modification for the structural and functional diversity of ginsenosides. In this study, the promiscuous UGT109A1 from was used to synthesize unnatural ginsenosides from natural ginsenosides. UGT109A1 was heterologously expressed in and then purified by Ni-NTA affinity chromatography. Ginsenosides Re, Rf, Rh1, and R1 were selected as the substrates to produce the corresponding derivatives by the recombinant UGT109A1. The results showed that UGT109A1 could transfer a glucosyl moiety to C3-OH of ginsenosides Re and R1, and C3-OH and C12-OH of ginsenosides Rf and Rh1, respectively, to produce unnatural ginsenosides 3,20-di--β-d-glucopyranosyl-6--[α-l-rhamnopyrano-(1→2)-β-d-glucopyranosyl]-dammar-24-ene-3β,6α,12β,20-tetraol (), 3,20-di--β-d-glucopyranosyl-6--[β-d-xylopyranosyl-(1→2)-β-d-glucopyranosyl]-dammar-24-ene-3β,6α,12β,20-tetraol (), 3--β-d-glucopyranosyl-6--[β-d-glucopyranosyl-(1→2)-β-d-glucopyranosyl]-dammar-24-ene-3β,6α,12β,20-tetraol (), 3,12-di--β-d-glucopyranosyl-6--[βd-glucopyranosyl-(1→2)-β-d-glucopyranosyl]-dammar-24-ene-3β,6α,12β,20-tetraol (), 3,6-di--β-d-glucopyranosyl-dammar-24-ene-3β,6α,12β,20S-tetraol (), and 3,6,12-tri--β-d-glucopyranosyl-dammar-24-ene-3β,6α,12β,20S-tetraol (). Among the above products, , , , and are new compounds. The maximal activity of UGT109A1 was achieved at the temperature of 40 °C, in the pH range of 8.0⁻10.0. The activity of UGT109A1 was considerably enhanced by Mg, Mn, and Ca, but was obviously reduced by Cu, Co, and Zn. The study demonstrated that UGT109A1 was effective in producing a series of unnatural ginsenosides through enzymatic reactions, which could pave a way to generate promising leads for new drug discovery.
糖基化是一种重要的生物修饰,由 UDP-糖基转移酶(UGTs)催化,可提高人参皂苷的结构和功能多样性。本研究利用 来源的多功能UGT109A1 从天然人参皂苷中合成非天然人参皂苷。将 UGT109A1 在 中异源表达,并通过 Ni-NTA 亲和层析进行纯化。选择人参皂苷 Re、Rf、Rh1 和 R1 作为底物,通过重组 UGT109A1 生成相应的衍生物。结果表明,UGT109A1 可分别将一个葡萄糖基转移到人参皂苷 Re 和 R1 的 C3-OH、Rf 和 Rh1 的 C3-OH 和 C12-OH 上,生成非天然人参皂苷 3,20-二--β-D-吡喃葡萄糖基-6--[α-L-鼠李吡喃糖基-(1→2)-β-D-吡喃葡萄糖基]-达玛-24-烯-3β,6α,12β,20-四醇()、3,20-二--β-D-吡喃葡萄糖基-6--[β-D-木吡喃糖基-(1→2)-β-D-吡喃葡萄糖基]-达玛-24-烯-3β,6α,12β,20-四醇()、3--β-D-吡喃葡萄糖基-6--[β-D-吡喃葡萄糖基-(1→2)-β-D-吡喃葡萄糖基]-达玛-24-烯-3β,6α,12β,20-四醇()、3,12-二--β-D-吡喃葡萄糖基-6--[β-D-吡喃葡萄糖基-(1→2)-β-D-吡喃葡萄糖基]-达玛-24-烯-3β,6α,12β,20-四醇()、3,6-二--β-D-吡喃葡萄糖基达玛-24-烯-3β,6α,12β,20-四醇()和 3,6,12-三--β-D-吡喃葡萄糖基达玛-24-烯-3β,6α,12β,20-四醇()。上述产物中,、、、和 是新化合物。UGT109A1 的最大活性在 40°C 时达到,在 pH8.0⁻10.0 范围内。Mg、Mn 和 Ca 显著增强了 UGT109A1 的活性,而 Cu、Co 和 Zn 则明显降低了其活性。该研究表明,UGT109A1 通过酶反应有效地合成了一系列非天然人参皂苷,为新药发现提供了有前途的先导化合物。